Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation

Lv,Shan; Wu,Lin; Cheng,Peng; Yu,Jing; Zhang,Aisen; Zha,Juanmin; Liu,Juan; Wang,Long; Di,Wenjuan; Hu,Miao; Qi,Hanmei; Li,Yujie; Ding,Guoxian

doi:10.3892/etm_00000095

Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation

Authors:
- Shan Lv
- Lin Wu
- Peng Cheng
- Jing Yu
- Aisen Zhang
- Juanmin Zha
- Juan Liu
- Long Wang
- Wenjuan Di
- Miao Hu
- Hanmei Qi
- Yujie Li
- Guoxian Ding
View Affiliations

Affiliations: Department of Geratology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, P.R. China
Published online on: July 1, 2010 https://doi.org/10.3892/etm_00000095
Pages: 603-610

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies on the relationship between obesity and bone have recently become widespread. The aim of this study was to investigate the effect of obesity on bone, utilizing a diet-induced obese mouse model, and to explore the role of free fatty acids (FFAs) in the osteogenesis/adipogenesis of mouse bone marrow-derived mesenchymal stem cells (BMSCs). An obese mouse model was established by a high-fat diet (HFD). Proximal femurs were collected at sacrifice, and bone mineral density (BMD) in the proximal femurs was measured by dual-energy X-ray absorptiometry. Bone histomorphometry was performed using undecalcified sections of the proximal femurs. The effect of obesity on the differentiation of mouse BMSCs was assessed by colony formation assays and gene expression analysis. In vitro, various osteogenic and adipogenic genes were determined by real-time quantitative PCR in mouse BMSCs after exposure to conditioned medium (CM) from FFA-treated 3T3-L1 adipocytes. Western blotting was further performed to analyze the representative protein expression of PPARγ and Runx2. BMD and trabecular thickness were significantly greater in the HFD mice than in the control mice. CFU-osteo assay showed significantly increased osteogenesis of BMSCs. The mRNA level of Runx2 was significantly higher, while PPARγ and Pref-1 were significantly lower in BMSCs from the HFD mice compared to the control mice. In mouse BMSCs, the Sox9 and Runx2 genes were significantly up-regulated after exposure to CM from FFA-treated adipocytes, while PPARγ and CEBP-α were significantly down-regulated. Osteogenesis was significantly increased, while adipogenesis was significantly decreased. In conclusion, HFD-induced obesity may play a protective role in bone formation by concomitantly promoting osteogenic and suppressing adipogenic differentiation of BMSCs through factors secreted by FFA-treated adipocytes.

View Figures

View References

1.	Wellen KE and Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 112:1785–1788. 2003. View Article : Google Scholar : PubMed/NCBI
2.	Raisz LG: Pathogenesis of osteoporosis: concepts, conflict, and prospects. J Clin Invest. 115:3318–3325. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Melton LJ III: Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res. 18:1139–1141. 2003. View Article : Google Scholar : PubMed/NCBI
4.	Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW and Lewis-Barned NJ: Bone mineral density in girls with forearm fractures. J Bone Miner Res. 13:143–148. 1998. View Article : Google Scholar : PubMed/NCBI
5.	Nagasaki K, Kikuchi T, Hiura M and Uchiyama M: Obese Japanese children have low bone mineral density after puberty. J Bone Miner Metab. 22:376–381. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Clark EM, Ness AR and Tobias JH: Adipose tissue stimulates bone growth in prepubertal children. J Clin Endocrinol Metab. 91:2534–2541. 2006. View Article : Google Scholar : PubMed/NCBI
7.	Reid IR: Relationships among body mass, its components, and bone. Bone. 31:547–555. 2002.PubMed/NCBI
8.	Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ and Mittelman SD: Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 94:3387–3393. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Beresford JN, Bennett JH, Devlin C, Leboy PS and Owen ME: Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci. 102:341–351. 1992.PubMed/NCBI
10.	Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H and Meunier PJ: Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2:595–610. 1987. View Article : Google Scholar
11.	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
12.	Reid IR: Relationships between fat and bone. Osteoporos Int. 19:595–606. 2008. View Article : Google Scholar
13.	Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW and Zhao LJ: Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 23:17–29. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z and Ruderman N: Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes. 54:3458–3465. 2005.PubMed/NCBI
15.	Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M and Furuichi K: Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G protein-coupled receptor. Biochem Biophys Res Commun. 326:744–751. 2005. View Article : Google Scholar : PubMed/NCBI
16.	Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y and Inagaki N: The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology. 149:574–579. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Grey A: Fatty acids and bone. Clinic Rev Bone Miner Metab. 7:210–215. 2009. View Article : Google Scholar
18.	Cornish J, MacGibbon A, Lin JM, Watson M, Callon KE, Tong PC, Dunford JE, van der Does Y, Williams GA, Grey AB, Naot D and Reid IR: Modulation of osteoclastogenesis by fatty acids. Endocrinology. 149:5688–5695. 2008. View Article : Google Scholar : PubMed/NCBI
19.	Watkins BA, Li Y, Allen KG, Hoffmann WE and Seifert MF: Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr. 130:2274–2284. 2000.PubMed/NCBI
20.	Morley JE and Baumgartner RN: Cytokine-related aging process. J Gerontol A Biol Sci Med Sci. 59:M924–M929. 2004. View Article : Google Scholar : PubMed/NCBI
21.	Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H and Swick AG: Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept. 92:73–78. 2000. View Article : Google Scholar : PubMed/NCBI
22.	Frühbeck G: Intracellular signalling pathways activated by leptin. Biochem J. 393:7–20. 2006.
23.	Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD and Liao EY: Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 21:1648–1656. 2006. View Article : Google Scholar : PubMed/NCBI
24.	Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H and Shimomura I: Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun. 331:520–526. 2005. View Article : Google Scholar : PubMed/NCBI
25.	Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD and Thieringer R: Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem. 276:12629–12635. 2001.
26.	Shintani M, Nishimura H, Yonemitsu S, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y and Nakao K: Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate. Metabolism. 49:326–330. 2000. View Article : Google Scholar : PubMed/NCBI